Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.80x is 149% below its 4-year average of 3.71x, near the low end of its 4-year range (-4.32x–10.05x).
As of the fiscal period ended Friday, December 31, 2021. 0.40% above its 12-month average of -1.81x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2021 (2021-12-31): -1.80x.
INTEREST COVERAGE RATIO
-1.80x
INTEREST COVERAGE RATIO AVG TTM
-1.81x
INTEREST COVERAGE RATIO AVG 3Y
2.35x
INTEREST COVERAGE RATIO AVG 5Y
3.71x
INTEREST COVERAGE RATIO AVG 10Y
3.71x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.40%
CURRENT VS 3Y AVG
-176.57%
CURRENT VS 5Y AVG
-148.57%
CURRENT VS 10Y AVG
-148.57%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 329 covered companies
CURRENT VS SECTOR MEDIAN
+57.09%
vs the sector median at left
HeartBeam, Inc.
Market Cap
$34.65M
Interest Coverage Ratio
-1.80x
TTM Avg
-1.81x
3Y Avg
2.35x
5Y Avg
3.71x
Market Cap
$35.68M
Interest Coverage Ratio
47.58x
TTM Avg
47.58x
3Y Avg
47.58x
5Y Avg
47.58x
Market Cap
$36.54M
Interest Coverage Ratio
-735.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.79M
Interest Coverage Ratio
-87.92x
TTM Avg
13.24x
3Y Avg
16.68x
5Y Avg
16.68x
Market Cap
$36.23M
Interest Coverage Ratio
-33.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.26M
Interest Coverage Ratio
-0.75x
TTM Avg
0.33x
3Y Avg
0.47x
5Y Avg
0.65x
Market Cap
$37.67M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.34M
Interest Coverage Ratio
-0.13x
TTM Avg
0.53x
3Y Avg
0.64x
5Y Avg
0.43x
Market Cap
$38.41M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartBeam, Inc. (BEAT) | $34.65M | -1.80x | -1.81x | 2.35x | 3.71x |
| Elutia Inc (ELUT)vs › | $35.68M | 47.58x | 47.58x | 47.58x | 47.58x |
| BriaCell Therapeutics Corp. (BCTX)vs › | $36.54M | -735.69x | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $36.79M | -87.92x | 13.24x | 16.68x | 16.68x |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.23M | -33.29x | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $36.26M | -0.75x | 0.33x | 0.47x | 0.65x |
| Edesa Biotech, Inc. (EDSA)vs › | $37.67M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.34M | -0.13x | 0.53x | 0.64x | 0.43x |
| Incannex Healthcare Limited (IXHL)vs › | $38.41M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | N/A | N/A | N/A | N/A |
Interest Coverage
-1.8x
Debt/Equity
0.00
Current Ratio
3.66
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-12-31 | -1.80x |
| 2021-09-30 | -0.60x |
| 2021-06-30 | -0.55x |
| 2021-03-31 | -2.36x |
| 2020-12-31 | -3.73x |
| 2020-09-30 | -4.32x |
| 2020-06-30 | -2.05x |
| 2020-03-31 | -1.37x |
| 2019-12-31 | 10.05x |
| 2019-09-30 | 10.03x |
| 2019-06-30 | 9.19x |
| 2019-03-31 | 8.23x |
| 2018-12-31 | 9.89x |
| 2018-09-30 | 9.74x |
| 2018-06-30 | 7.78x |
| 2018-03-31 | 8.19x |
| 2017-12-31 | 7.07x |
| 2017-09-30 | 3.42x |
| 2013-03-31 | 60.56x |
| 2009-12-31 | -2816.50x |
| 2009-09-30 | -2378.00x |
| 2009-06-30 | 643.00x |
| 2009-03-31 | 198.50x |
